Live Breaking News & Updates on Adaptimmune Therapeutics Company Profile

Stay updated with breaking news from Adaptimmune therapeutics company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Q2 2024 EPS Estimates for Adaptimmune Therapeutics plc Decreased by Analyst (NASDAQ:ADAP)

Adaptimmune Therapeutics plc (NASDAQ:ADAP – Free Report) – Leerink Partnrs cut their Q2 2024 EPS estimates for shares of Adaptimmune Therapeutics in a research report issued on Wednesday, May 15th. Leerink Partnrs analyst J. Chang now forecasts that the biotechnology company will post earnings of ($0.17) per share for the quarter, down from their previous […] ....

United Kingdom , United States , Leerink Partnrs , Employer Solutions Trustee Ltd , Capital Partners , Adaptimmune Therapeutics Company Profile , Key Client Fiduciary Advisors , Columbia Advisory Partners , Adaptimmune Therapeutics , Free Report , Adaptimmune Therapeutic , Get Free Report , Hill Capital Management , Solutions Trustee Ltd , Advisory Partners , Focus Capital Partners , Client Fiduciary Advisors , Adaptimmune Therapeutics Daily ,

Adaptimmune Therapeutics plc (NASDAQ:ADAP) Short Interest Update

Adaptimmune Therapeutics plc (NASDAQ:ADAP) Short Interest Update
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , United States , Columbia Advisory Partners , Harbor Capital Advisors Inc , Adaptimmune Therapeutics Company Profile , Marquette Asset Management , Capital Partners , Employer Solutions Trustee Ltd , Adaptimmune Therapeutics , Get Free Report , Advisory Partners , Solutions Trustee Ltd , Focus Capital Partners , Asset Management , Harbor Capital Advisors , Capital Advisors , Adaptimmune Therapeutics Daily ,

Adaptimmune Therapeutics (NASDAQ:ADAP) Shares Gap Up to $1.01

Adaptimmune Therapeutics plc (NASDAQ:ADAP – Get Free Report) gapped up before the market opened on Tuesday . The stock had previously closed at $1.01, but opened at $1.04. Adaptimmune Therapeutics shares last traded at $1.08, with a volume of 119,471 shares trading hands. Wall Street Analysts Forecast Growth Separately, StockNews.com assumed coverage on shares of […] ....

United Kingdom , United States , Capital Partners , Harbor Capital Advisors Inc , Acuitas Investments , Marquette Asset Management , Key Client Fiduciary Advisors , Adaptimmune Therapeutics Company Profile , Adaptimmune Therapeutics , Get Free Report , Client Fiduciary Advisors , Capital Advisors , Asset Management , Twin Focus Capital Partners , Adaptimmune Therapeutics Daily , Nasdaq Adap ,

Adaptimmune Therapeutics (NASDAQ:ADAP) Shares Gap Up to $1.35

Adaptimmune Therapeutics (NASDAQ:ADAP) Shares Gap Up to $1.35
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , United States , Citigroup Inc , Asset Management , Renaissance Technologies , Adaptimmune Therapeutics Company Profile , Baillie Gifford Co , America Corp , Adaptimmune Therapeutics , Get Free Report , Adaptimmune Therapeutics Daily ,

Adaptimmune Therapeutics (NASDAQ:ADAP) Shares Up 3.8%

Adaptimmune Therapeutics (NASDAQ:ADAP) Shares Up 3.8%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , United States , Barclays Plc , Adaptimmune Therapeutics Company Profile , Square Capital , Goldman Sachs Group Inc , Adaptimmune Therapeutics , Get Free Report , Sigma Investments , Sachs Group , Adaptimmune Therapeutics Daily ,